MGI(SH:688114) Xin Lang Cai Jing·2026-02-23 09:29Core Viewpoint - The company, BGI Genomics (688114.SH), announced the sale of its wholly-owned subsidiary Complete Genomics, Inc. to Swiss Rockets AG for approximately $50 million, which is expected to enhance profitability and operational efficiency [1] Group 1: Transaction Details - BGI Genomics plans to divest 100% equity of Complete Genomics, Inc. after separating related assets and liabilities [1] - The transaction is valued at around $50 million [1] Group 2: Licensing Agreement - A licensing agreement amendment has been signed between MGI US LLC, CGI, and Swiss Rockets, granting exclusive rights to the StandardMPS sequencing technology in the U.S. and Canada [1] - The agreement also includes a general license for the universal sequencing technology [1] Group 3: Financial Impact - The transaction is anticipated to provide significant direct benefits and improve cash flow for the company [1] - It is expected to enhance overall profitability and operational efficiency [1]